All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ABCELLERA BIOLOGICS INC. Last Reported: 2/29/2024 Stock Symbol: ABCL

Business Address

2215 YUKON STREET

VANCOUVER , BC CA V5Y 0A1

Mailing Address

2215 YUKON STREET

VANCOUVER , BC CA V5Y 0A1
Phone Number: (604) 559-9005 / State Incorporated: BC / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Cash and Cash Equivalents $133,300,000.00 $172,422,000.00 $179,747,000.00 $193,017,000.00 $371,973,000.00 $790,615,000.00 $545,718,000.00 $8,200,000.00 $517,694,000.00 $792,571,000.00 $685,795,000.00 $594,116,000.00 -- -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- $2,799,000.00 $23,371,000.00 $903,000.00 -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $871,985,000.00 $919,518,000.00 $930,735,000.00 $940,653,000.00 $1,045,669,000.00 $1,143,955,000.00 $1,174,378,000.00 $929,800,000.00 $803,747,000.00 $864,002,000.00 $907,982,000.00 $813,325,000.00 -- -- -- -- --
Property Plant and Equipement -- $277,209,000.00 $259,640,000.00 $233,187,000.00 $200,602,000.00 $149,178,000.00 $122,049,000.00 $111,616,000.00 $91,584,000.00 $87,479,000.00 $34,618,000.00 $17,923,000.00 -- -- -- -- --
Intangible Assets Net $120,425,000.00 $124,076,000.00 $126,747,000.00 $128,845,000.00 $142,548,000.00 $143,179,000.00 $145,785,000.00 $148,392,000.00 $148,821,000.00 $110,223,000.00 $112,688,000.00 $115,153,000.00 -- -- -- -- --
Goodwill $47,800,000.00 $47,806,000.00 $47,806,000.00 $47,806,000.00 $47,806,000.00 $47,806,000.00 $47,806,000.00 $47,806,000.00 $49,457,000.00 $31,500,000.00 $31,500,000.00 $31,500,000.00 -- -- -- -- --
Other Assets $94,244,000.00 $80,694,000.00 $113,446,000.00 $89,845,000.00 $49,066,000.00 $43,842,000.00 $43,389,000.00 $30,642,000.00 $31,616,000.00 $15,947,000.00 $9,548,000.00 $8,388,000.00 -- -- -- -- --
Total Assets $1,488,094,000.00 $1,512,190,000.00 $1,537,166,000.00 $1,497,919,000.00 $1,552,409,000.00 $1,593,784,000.00 $1,592,289,000.00 $1,318,569,000.00 $1,172,732,000.00 $1,151,856,000.00 $1,128,523,000.00 $1,005,536,000.00 -- -- -- -- --
Accounts Payable -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $335,776,000.00 $329,415,000.00 $342,339,000.00 $289,419,000.00 $302,237,000.00 $380,928,000.00 $384,782,000.00 $292,836,000.00 $219,335,000.00 $184,177,000.00 $171,399,000.00 $175,028,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $121,052,000.00 $109,384,000.00 $96,423,000.00 $81,630,000.00 $64,384,000.00 $56,001,000.00 $44,726,000.00 $35,357,000.00 $26,945,000.00 $21,669,000.00 $14,562,000.00 $5,919,000.00 -- -- -- -- --
Accumulated Other Comprehensive Loss $-1,720,000.00 $-1,460,000.00 $-1,899,000.00 $-2,021,000.00 $-717,000.00 $576,000.00 $787,000.00 $280,000.00 $644,000.00 $2,152,000.00 -- -- -- -- -- -- --
Accumulated Deficit $279,787,000.00 $326,937,000.00 $355,547,000.00 $386,075,000.00 $456,078,000.00 $429,454,000.00 $436,239,000.00 $267,666,000.00 $207,720,000.00 $229,100,000.00 $231,423,000.00 $114,202,000.00 -- -- -- -- --
Total Stockholders' Equity $1,152,318,000.00 $1,182,775,000.00 $1,194,827,000.00 $1,208,500,000.00 $1,250,172,000.00 $1,212,856,000.00 $1,207,507,000.00 $1,025,733,000.00 $953,397,000.00 $967,679,000.00 $957,124,000.00 $830,508,000.00 $89,256,000.00 $90,892,000.00 $83,689,000.00 $10,252,000.00 $11,609,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $1,488,094,000.00 $1,512,190,000.00 $1,537,166,000.00 $1,497,919,000.00 $1,552,409,000.00 $1,593,784,000.00 $1,592,289,000.00 $1,318,569,000.00 $1,172,732,000.00 $1,151,856,000.00 $1,128,523,000.00 $1,005,536,000.00 -- -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $175,658,000.00 $127,036,000.00 $89,120,000.00 $52,647,000.00 $79,634,000.00 $53,052,000.00 $26,366,000.00 $62,062,000.00 $17,450,000.00 $27,403,000.00 $12,352,000.00 -- $7,495,000.00 $9,144,000.00 $4,118,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $275,232,000.00 $200,000,000.00 $61,445,000.00 $77,066,000.00 $63,648,000.00 $145,944,000.00 $91,631,000.00 $170,790,000.00 $113,012,000.00 $79,409,000.00 $44,667,000.00 -- $29,991,000.00 $18,861,000.00 $6,779,000.00 -- --
Loss from Operations $-237,207,000.00 $-171,154,000.00 $-116,263,000.00 $-64,874,000.00 $37,735,000.00 $216,553,000.00 $224,950,000.00 $204,413,000.00 $122,860,000.00 $150,975,000.00 $158,074,000.00 -- $-4,744,000.00 $-2,976,000.00 $-2,122,000.00 -- --
Loss Before Income Taxes $-174,029,000.00 $-39,276,000.00 $-38,004,000.00 $-48,148,000.00 $270,511,000.00 $223,924,000.00 $230,809,000.00 $219,149,000.00 $134,439,000.00 $159,414,000.00 $161,487,000.00 -- $1,917,000.00 $4,610,000.00 $-2,093,000.00 -- --
Earnings Per Share Basic $-0.51 $-0.10 $-0.24 $-0.14 $0.09 $-0.02 $0.59 $0.56 $0.34 $0.42 $0.43 -- $0.01 $0.02 $-0.01 -- --
Weighted Average Shares Basic 289,166,486 288,750,387 288,905,587 287,767,136 284,639,599 284,686,542 283,895,020 275,763,745 273,642,542 270,953,541 269,697,212 -- 153,049,739 152,326,424 151,859,924 -- --
Earnings Per Share Diluted $-0.51 $-0.34 $-0.24 $-0.14 $0.08 $-0.02 $0.54 $0.48 $0.29 $0.36 $0.37 -- $-0.02 $0.03 $-0.01 -- --
Weighted Average Shares Diluted 289,166,486 288,750,387 288,357,081 287,767,136 314,183,994 313,361,183 311,482,017 318,294,236 323,323,053 321,555,443 320,282,747 -- 237,723,530 226,039,616 151,859,924 -- --
Common Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Outstanding 290,824,970 286,851,595 286,851,595 286,851,595 285,761,492 285,052,302 284,521,181 283,257,104 281,151,877 276,982,678 270,925,930 269,497,768 -- -- -- -- --
Common Stock Value $753,199,000.00 $747,914,000.00 $744,756,000.00 $742,816,000.00 $730,427,000.00 $726,825,000.00 $725,755,000.00 $722,430,000.00 $718,088,000.00 $714,758,000.00 $711,139,000.00 $710,387,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com